Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The prognostic impact of soluble and vesicular HLA-G and its relationship to circulating tumor cells in neoadjuvant treated breast cancer patients
Lisa König, Sabine Kasimir‐Bauer, Oliver Hoffmann, et al.
Human Immunology (2016) Vol. 77, Iss. 9, pp. 791-799
Closed Access | Times Cited: 76

Showing 1-25 of 76 citing articles:

Circulating and disseminated tumour cells — mechanisms of immune surveillance and escape
Malte Mohme, Sabine Riethdorf, Klaus Pantel
Nature Reviews Clinical Oncology (2016) Vol. 14, Iss. 3, pp. 155-167
Closed Access | Times Cited: 528
Endocrine Resistance in Hormone Receptor Positive Breast Cancer–From Mechanism to Therapy
Aradhana Rani, Justin Stebbing, Georgios Giamas, et al.
Frontiers in Endocrinology (2019) Vol. 10
Open Access | Times Cited: 188
The Role of Immune Escape and Immune Cell Infiltration in Breast Cancer
André Steven, Barbara Seliger
Breast Care (2018) Vol. 13, Iss. 1, pp. 16-21
Open Access | Times Cited: 145
Immune regulation of metastasis: mechanistic insights and therapeutic opportunities
Olga Blomberg, Lorenzo Spagnuolo, Karin E. de Visser
Disease Models & Mechanisms (2018) Vol. 11, Iss. 10
Open Access | Times Cited: 126
Heterogeneity of HLA-G Expression in Cancers: Facing the Challenges
Aifen Lin, Wei‐Hua Yan
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 121
Recent Advances in Our Understanding of HLA-G Biology: Lessons from a Wide Spectrum of Human Diseases
Fabio Morandi, Roberta Rizzo, Enrico Fainardi, et al.
Journal of Immunology Research (2016) Vol. 2016, pp. 1-14
Open Access | Times Cited: 118
Elevated levels of extracellular vesicles are associated with therapy failure and disease progression in breast cancer patients undergoing neoadjuvant chemotherapy
Lisa König, Sabine Kasimir‐Bauer, Ann‐Kathrin Bittner, et al.
OncoImmunology (2017) Vol. 7, Iss. 1, pp. e1376153-e1376153
Open Access | Times Cited: 106
Mapping the tumour human leukocyte antigen (HLA) ligandome by mass spectrometry
Lena Katharina Freudenmann, Ana Marcu, Stefan Stevanović
Immunology (2018) Vol. 154, Iss. 3, pp. 331-345
Open Access | Times Cited: 104
HLA-G 3′ untranslated region variants +3187G/G, +3196G/G and +3035T define diametrical clinical status and disease outcome in epithelial ovarian cancer
Esther Schwich, Vera Rebmann, Rafael Tomoya Michita, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 103
Similarities Between Embryo Development and Cancer Process Suggest New Strategies for Research and Therapy of Tumors: A New Point of View
Giovanni Manzo
Frontiers in Cell and Developmental Biology (2019) Vol. 7
Open Access | Times Cited: 97
Survival Mechanisms and Influence Factors of Circulating Tumor Cells
Wenchao Wang, Xiaofeng Zhang, Jian Peng, et al.
BioMed Research International (2018) Vol. 2018, pp. 1-9
Open Access | Times Cited: 91
The Role of Circulating Tumor Cells in the Metastatic Cascade: Biology, Technical Challenges, and Clinical Relevance
Hassan Dianat‐Moghadam, Mehdi Azizi, Zahra Eslami‐S, et al.
Cancers (2020) Vol. 12, Iss. 4, pp. 867-867
Open Access | Times Cited: 78
Harnessing the potential of HLA-G in cancer therapy: advances, challenges, and prospects
Siyuan Wang, Jiaxin Wang, Yu Xia, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Mechanism of immune evasion in breast cancer
Mozhi Wang, Changwang Zhang, Yongxi Song, et al.
OncoTargets and Therapy (2017) Vol. Volume 10, pp. 1561-1573
Open Access | Times Cited: 80
HLA-mediated tumor escape mechanisms that may impair immunotherapy clinical outcomes via T-cell activation
Josefa Antonia Rodrı́guez
Oncology Letters (2017) Vol. 14, Iss. 4, pp. 4415-4427
Open Access | Times Cited: 79
NK cells-directed therapies target circulating tumor cells and metastasis
Hassan Dianat‐Moghadam, Amir Mahari, Maryam Heidarifard, et al.
Cancer Letters (2020) Vol. 497, pp. 41-53
Closed Access | Times Cited: 68
HLA-G: A New Immune Checkpoint in Cancer?
Daniëlle Krijgsman, Jessica Roelands, Wouter Hendrickx, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 12, pp. 4528-4528
Open Access | Times Cited: 66
HLA-G Neo-Expression on Tumors
Maria Loustau, François Anna, Raphaelle Dréan, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 58
HLA-G and Other Immune Checkpoint Molecules as Targets for Novel Combined Immunotherapies
Fabio Morandi, Irma Airoldi
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 2925-2925
Open Access | Times Cited: 30
The Potential of HLA-G-Bearing Extracellular Vesicles as a Future Element in HLA-G Immune Biology
Vera Rebmann, Lisa König, Fabiola da Silva Nardi, et al.
Frontiers in Immunology (2016) Vol. 7
Open Access | Times Cited: 58
Tuning cancer fate: the unremitting role of host immunity
Bianca Calì, Barbara Molon, Antonella Viola
Open Biology (2017) Vol. 7, Iss. 4, pp. 170006-170006
Open Access | Times Cited: 53
HLA‐G: Function, polymorphisms and pathology
Antonio Arnaiz‐Villena, Ignacio Juárez, Fabio Suárez‐Trujillo, et al.
International Journal of Immunogenetics (2020) Vol. 48, Iss. 2, pp. 172-192
Open Access | Times Cited: 49
Tumor‐derived exosomes (TDEs): How to avoid the sting in the tail
MeiHua Wan, Bo Ning, Sarah Spiegel, et al.
Medicinal Research Reviews (2019) Vol. 40, Iss. 1, pp. 385-412
Open Access | Times Cited: 43
Breast Cancer Tumor Microenvironment and Molecular Aberrations Hijack Tumoricidal Immunity
Huey‐Jen Lin, Yingguang Liu, Denene Lofland, et al.
Cancers (2022) Vol. 14, Iss. 2, pp. 285-285
Open Access | Times Cited: 22
Intercellular transfer of HLA‐G: its potential in cancer immunology
Aifen Lin, Wei‐Hua Yan
Clinical & Translational Immunology (2019) Vol. 8, Iss. 9
Open Access | Times Cited: 41
Page 1 - Next Page

Scroll to top